Monday, 11 April, 2011: Marvao Medical, a Galway-based medical device company focused on developing new products that reduce the risk of catheter related infections, commenced its First in Man clinical study of its NexSite vascular access catheter in University Hospital Galway in late March, and enrolled their first patient on April 8, 2011. Catheters equipped...
more
News
Marvao Medical Secures Investment
February 9th 2011: Marvao Medical Devices, an early stage lrish medical device company focused on commercializing new products that reduce the risk of catheter related infections, has secured investment of €1.3 million in a funding round led by the AIB Seed Capital Fund along with earlier private investors including Harmac Medical Products and the Western...
more
Welcome
According to the US Centers for Disease Control, the magnitude of Catheter Related Bloodstream Infections (CRBSI) is an estimated 200,000 to 400,000 episodes annually. Annually, the associated costs of treating CRBSI may exceed $2 billion.
Marvao Medical specializes in the development, manufacturing and marketing of innovative medical devices to address unmet clinical needs and deliver high quality of care to the patient population. Marvao Medical is focused on “Promoting Safer Therapy” by reducing the incidence of CRBSI.
Marvao Medical’s NexSitetm technology aims to reduce the rate of CRBSI by managing the exit sites of Central Venous Catheters by promoting the formation of a biological seal around the catheter. This seal is intended to create a natural barrier around the catheter exit site thus blocking this route for potential infection. NexSitetm technology is expected to play a role in lowering the rate of CBRSI.